Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Prostate Adenocarcinoma × entinostat × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Urinary Bladder Neoplasms 2 Recurrence 2 Pancreatic Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Penile Neoplasms 1 Oropharyngeal Neoplasms 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Lymphoma 1 Head and Neck Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1 Breast Neoplasms, Male 1 Brain Neoplasms 1 Anus Neoplasms 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Radiotherapy 3 Radiation 3 Magnetic Resonance Spectroscopy 3 relugolix 2 luprolide acetate gel depot 2 enzalutamide 2 bicalutamide 2 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2 Specimen Handling 2 Radiosurgery 2 Leuprolide 2 Goserelin 2 Biopsy 2 radium Ra 223 dichloride 1 niraparib 1 histrelin 1 flibanserin 1 darolutamide 1 abiraterone 1 X-Rays 1 Triptorelin Pamoate 1 Surgical Procedures, Operative 1 Salicylic Acid 1 Radiotherapy, Image-Guided 1 Radiation Dose Hypofractionation 1 Proton Therapy 1 Prednisone 1 Lymph Node Excision 1 Glutamate Carboxypeptidase II 1 Flutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡